Skip Navigation

Vaccine Safety Bibliography - January 2012

1.   Adult immunizations. Treat Guidel Med Lett. 2011 Dec;9(112):75-82.

2.   Increased transmission and outbreaks of measles, European Region, 2011. Wkly Epidemiol Rec. 2011 Dec 2; 86(49):559-64.:

3.   Abuali MM, Arnon R, Posada R. An update on immunizations before and after transplantation in the pediatric solid organ transplant recipient. Pediatr Transplant. 2011 Dec; 15(8):770-7.

4.   Ademokun A, Wu YC, Martin V, Mitra R, Sack U, Baxendale H, Kipling D, Dunn-Walters DK. Vaccination-induced changes in human B-cell repertoire and pneumococcal IgM and IgA antibody at different ages. Aging Cell. 2011 Dec; 10(6):922-30.

5.   Adler S, Krivine A, Weix J, Rozenberg F, Launay O, Huesler J, Guillevin L, Villiger PM. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study. Rheumatology (Oxford). 2011 Dec 14. [Epub ahead of print].

6.   Al-Mendalawi MD. Bacillus Calmette-Guerins vaccination at birth causing tuberculous granulomatous lymphadenitis. Saudi Med J. 2011 Dec; 32(12):1315.

7.   Alfonsi V, D'Ancona F, Giambi C, Nacca G, Rota MC; Regional Coordinators for Infectious Diseases and Vaccinations. Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy. Health Policy. 2011 Dec; 103(2-3):176-83.

8.   Allison MA, Cohn AC, Stokley S, Crane LA, O'Leary ST, Hurley LP, Babbel CI, Dong F, Gahm C, Temte JL, Kempe A. Timing of adolescent meningococcal conjugate vaccination attitudes and practices of pediatricians and family medicine physicians. Am J Prev Med. 2011 Dec; 41(6):581-7.

9.   Anderson EJ. Intussusception risk of rotavirus vaccination. N Engl J Med. 2011 Dec 1; 365(22):2137-8; author reply 2138.

10.  Antai D. Gender inequities, relationship power, and childhood immunization uptake in Nigeria: a population-based cross-sectional study. Int J Infect Dis. 2011 Dec 23. [Epub ahead of print].

11.  Austvoll-Dahlgren A, Helseth S. Public health nurses' barriers and facilitators to the use of research in consultations about childhood vaccinations. Scand J Caring Sci. 2011 Dec 15. [Epub ahead of print].

12.  Azevedo RS, Amaku M. Modelling immunization strategies with cytomegalovirus vaccine candidates. Epidemiol Infect. 2011 Dec; 139(12):1818-26.

13.  Bayard V, Deantonio R, Contreras R, Tinajero O, Castrejon MM, Ortega-Barría E, Colindres RE. Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama. Int J Infect Dis. 2011 Dec 7. [Epub ahead of print].

14.  Belliveau MJ, Kratky V, Evans GA, Almeida DR, El-Defrawy S. Acute orbital inflammatory syndrome following H1N1 immunization. Can J Ophthalmol. 2011 Dec; 46(6):552-3.

15.  Betsch C, Wicker S. E-health use, vaccination knowledge and perception of own risk: Drivers of vaccination uptake in medical students. Vaccine. 2011 Dec 19. [Epub ahead of print].

16.  Biering-Sørensen S, Aaby P, Napirna BM, Roth A, Ravn H, Rodrigues A, Whittle H, Benn CS. Small Randomized Trial among Low-Birth-Weight Children of Bacillus Calmette-Guérin Vaccination at First Health Center Contact. Pediatr Infect Dis J. 2011 Dec 23. [Epub ahead of print].

17.  Bogaards JA, Kretzschmar M, Xiridou M, Meijer CJ, Berkhof J, Wallinga J. Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models. PLoS Med. 2011 Dec; 8(12):e1001147.

18.  Bogaards JA, Berkhof J. Assessment of herd immunity from human papillomavirus vaccination. Lancet Infect Dis. 2011 Dec; 11(12):896.

19.  Bond L, Nolan T. Making sense of perceptions of risk of diseases and vaccinations: a qualitative study combining models of health beliefs, decision-making and risk perception. BMC Public Health. 2011 Dec 20; 11(1):943. [Epub ahead of print].

20.  Breban R. Health newscasts for increasing influenza vaccination coverage: an inductive reasoning game approach. PLoS One. 2011; 6(12):e28300.

21.  Brown V. Adult immunization: Last on the list. Can Fam Physician. 2011 Dec; 57(12):1377-8.

22.  Brydak L, Roiz J, Faivre P, Reygrobellet C. Implementing an Influenza Vaccination Programme for Adults Aged ≥65 Years in Poland: A Cost-Effectiveness Analysis. Clin Drug Investig. 2011 Dec 27. [Epub ahead of print].

23.  Chandran SA, Ramachandra SS, Sekhar PS. National Family Health Survey-3 reported low full-immunization coverage rates in Andhra Pradesh, India: who is to be blamed? J Public Health (Oxf). 2011 Dec; 33(4):489-95.

24.  Chaves SS, Lopez AS, Watson TL, Civen R, Watson B, Mascola L, Seward JF. Varicella in Infants After Implementation of the US Varicella Vaccination Program. Pediatrics. 2011 Dec; 128(6):1071-7.

25.  Chow L, Fan M, Feng Z. Dynamics of a multigroup epidemiological model with group-targeted vaccination strategies. J Theor Biol. 2011 Dec 21; 291:56-64.

26.  Conway JM, Tuite AR, Fisman DN, Hupert N, Meza R, Davoudi B, English K, van den Driessche P, Brauer F, Ma J, Meyers LA, Smieja M, Greer A, Skowronski DM, Buckeridge DL, Kwong JC, Wu J, Moghadas SM, Coombs D, Brunham RC, Pourbohloul B. Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everything. BMC Public Health. 2011 Dec 14; 11(1):932. [Epub ahead of print].

27.  Cooper Robbins SC, Ward K, Skinner SR. School-based vaccination: A systematic review of process evaluations. Vaccine. 2011 Dec 6; 29(52):9588-99.

28.  Cooper Robbins SC, Pang C, Leask J. Australian Newspaper Coverage of Human Papillomavirus Vaccination, October 2006-December 2009. J Health Commun. 2011 Dec 2. [Epub ahead of print].

29.  Cortese MM, Leblanc J, White KE, Jerris RC, Stinchfield P, Preston KL, Meek J, Odofin L, Khizer S, Miller CA, Buttery V, Mijatovic-Rustempasic S, Lewis J, Parashar UD, Immergluck LC. Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine. Pediatrics. 2011 Dec; 128(6):e1474-81.

30.  de Soarez PC, Sartori AM, de Andrade Lagoa Nóbrega L, Itria A, Novaes HM. Cost-effectiveness analysis of a universal infant immunization program with meningococcal C conjugate vaccine in Brazil. Value Health. 2011 Dec; 14(8):1019-27.

31.  Dombkowski KJ, Reeves SL, Dong S, Stevenson J, Clark SJ. Assessing the burden of undeliverable immunization reminder and recall notifications. Prev Med. 2011 Dec 1; 53(6):424-6.

32.  Donovan B, Guy R, Fairley CK. Assessment of herd immunity from human papillomavirus vaccination - Authors' reply. Lancet Infect Dis. 2011 Dec; 11(12):896-7.

33.  Dorell C, Yankey D, Strasser S. Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, national immunization survey--teen, 2009. Clin Pediatr (Phila). 2011 Dec; 50(12):1116-24.

34.  Dunne EM, Manning J, Russell FM, Robins-Browne RM, Mulholland EK, Satzke C. The effect of pneumococcal vaccination on nasopharyngeal carriage of S. pneumoniae, H. influenzae, M. catarrhalis, and S. aureus in Fijian children. J Clin Microbiol. 2011 Dec 14. [Epub ahead of print].

35.  Durrieu G, Caillet C, Lacroix I, Jacquet A, Faucher A, Ouaret S, Sommet A, Perault-Pochat MC, Kreft-Jaïs C, Castot A, Damase-Michel C, Montastruc JL; le réseau français des centres de pharmacovigilance. [National Campaign of Vaccination against the Flu A (H1N1)v: National Follow-up of Pharmacovigilance]. Therapie. 2011 Nov-Dec; 66(6):527-40.

36.  Díez-Domingo J, Ridao-López M, Gutiérrez-Gimeno MV, Puig-Barberá J, Lluch-Rodrigo JA, Pastor-Villalba E. Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain). Vaccine. 2011 Dec 6; 29(52):9640-8.

37.  Elverdam B. 'It is only a pinprick': (or is it?): childhood vaccinations in general practice as 'matter out of place'. Anthropol Med. 2011 Dec; 18(3):339-50.

38.  Emmett GA, Schneider M. Office immunization. Prim Care. 2011 Dec; 38(4):729-45, ix.

39.  Escolano S, Farrington CP, Hill C, Tubert-Bitter P. Intussusception after rotavirus vaccination--spontaneous reports. N Engl J Med. 2011 Dec 1; 365(22):2139.

40.  Flohr C, Nagel G, Weinmayr G, Kleiner A, Williams HC, Aït-Khaled N, Strachan DP; the ISAAC Phase Two Study Group. Tuberculosis, bacillus Calmette-Guérin vaccination, and allergic disease: Findings from the International Study of Asthma and Allergies in Childhood Phase Two. Pediatr Allergy Immunol. 2011 Dec 23. [Epub ahead of print].

41.  Foucras G, Corbière F, Tasca C, Pichereaux C, Caubet C, Trumel C, Lacroux C, Franchi C, Burlet-Schiltz O, Schelcher F. Alloantibodies against MHC Class I: A Novel Mechanism of Neonatal Pancytopenia Linked to Vaccination. J Immunol. 2011 Dec 15; 187(12):6564-70.

42.  Franck L, Gay CL, Lynch M, Lee KA. Infant sleep after immunization: randomized controlled trial of prophylactic acetaminophen. Pediatrics. 2011 Dec; 128(6):1100-8.

43.  Frenck R Jr, Thompson A, Yeh SH, London A, Sidhu MS, Patterson S, Gruber WC, Emini EA, Scott DA, Gurtman A; 3011 Study Group. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously immunized with 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2011 Dec; 30(12):1086-91.

44.  Fujisaki R, Yamamura M, Abe S, Shimogawara K, Kasahara M, Nishiya H, Makimura M, Makimura K. A case study of measles vaccination for university students during the measles outbreak in Tokyo, Japan, 2007. J Infect Chemother. 2011 Dec 3. [Epub ahead of print].

45.  Garland SM. Human papillomavirus vaccination: where to now? Sex Transm Infect. 2011 Dec; 87 Suppl 2:ii23-ii24.

46.  Gaudino JA, Robison S. Risk factors associated with parents claiming personal-belief exemptions to school immunization requirements: Community and other influences on more skeptical parents in Oregon, 2006. Vaccine. 2011 Dec 14. [Epub ahead of print].

47.  Giaquinto C, Jackson AE, Vesikari T. Report of the Second European Expert Meeting on Rotavirus Vaccination. Vaccine. 2011 Dec 13. [Epub ahead of print].

48.  Grimprel E, Laudat F, Patterson S, Baker SA, Sidhu MS, Gruber WC, Emini EA, Scott DA. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants. Vaccine. 2011 Dec 6; 29(52):9675-83.

49.  Guthmann JP, Fonteneau L, Bonmarin I, Lévy-Bruhl D. Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010-2011. Vaccine. 2011 Dec 15. [Epub ahead of print].

50.  Hampton T. Outbreaks spur measles vaccine studies. JAMA. 2011 Dec 14; 306(22):2440-2.

51.  Hegde NR, Kaveri SV, Bayry J. Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination. Drug Discov Today. 2011 Dec; 16(23-24):1061-8.

52.  Heidelbaugh JJ. Immunizations as the nucleus of prevention. Prim Care. 2011 Dec; 38(4): xi-xii.

53.  Heijstek MW, Ott de Bruin LM, Borrow R, van der Klis F, Koné-Paut I, Fasth A, Minden K, Ravelli A, Abinun M, Pileggi G, Borte M, Bijl M, Wulffraat NM. Vaccination in paediatric patients with auto- immune rheumatic diseases: A systemic literature review for the European League against Rheumatism evidence-based recommendations. Autoimmun Rev. 2011 Dec; 11(2):112-22.

54.  Heininger U, Bachtiar NS, Bahri P, Dana A, Dodoo A, Gidudu J, Santos EM. The concept of vaccination failure. Vaccine. 2011 Dec 20. [Epub ahead of print].

55.  Hendrikx LH, Felderhof MK, Oztürk K, de Rond LG, van Houten MA, Sanders EA, Berbers GA, Buisman AM. Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age. Vaccine. 2011 Dec 9; 30(1):51-8.

56.  Hernandez PO, Javed S, Mendoza N, Lapolla W, Hicks LD, Tyring SK. Family history and herpes zoster risk in the era of shingles vaccination. J Clin Virol. 2011 Dec; 52(4):344-8.

57.  Hillson CM, Barash JH, Buchanan EM. Adult vaccination. Prim Care. 2011 Dec; 38(4):611-32, vii.

58.  Hinman AR, Orenstein WA, Schuchat A. Vaccine-preventable Diseases, Immunizations, and the Epidemic Intelligence Service. Am J Epidemiol. 2011 Dec 1; 174(11 Suppl):S16-22.

59.  Hof H, Oberdorfer K, Singer S, Holfelder M, Fahr A. [Pneumococcal sepsis in aged patients - implications for the vaccination of seniors against pneumococci]. Dtsch Med Wochenschr. 2011 Dec; 136(49):2562-4

60.  Huang JY, Sedlovskaya A, Ackerman JM, Bargh JA. Immunizing against prejudice: effects of disease protection on attitudes toward out-groups. Psychol Sci. 2011 Dec 1; 22(12):1550-6.

61.  Hung IF, Levin Y, To KK. Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 H1N1 vaccination. Vaccine. 2011 Dec 27. [Epub ahead of print].

62.  Ilia S, Spanaki AM, Raissaki M, Spoulou VI, Fitrolaki MD, Kanariou M, Tzanakaki G, Briassoulis G. Complicated pneumococcal meningitis in a fully vaccinated child: value of magnetic resonance imaging monitoring. Neuropediatrics. 2011 Dec; 42(6):240-4.

63.  Ioannidis JP, Manzoli L, De Vito C, D'Addario M, Villari P. Publication Delay of Randomized Trials on 2009 Influenza A (H1N1) Vaccination. PLoS One. 2011; 6(12):e28346.

64.  Janapatla RP, Chang HJ, Hsu MH, Hsieh YC, Lin TY, Chiu CH. Nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Alloiococcus otitidis in young children in the era of pneumococcal immunization, Taiwan. Scand J Infect Dis. 2011 Dec; 43(11-12):937-42.

65.  Jawad AF, Prak EL, Boyer J, McDonald-McGinn DM, Zackai E, McDonald K, Sullivan KE. A Prospective Study of Influenza Vaccination and a Comparison of Immunologic Parameters in Children and Adults with Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome). J Clin Immunol. 2011 Dec; 31(6):927-35.

66.  Kallweit U, Hidalgo H, Engel A, Baumann CR, Bassetti CL, Dahmen N. Post H1N1 vaccination narcolepsy-cataplexy with decreased CSF beta-amyloid. Sleep Med. 2011 Dec 13. [Epub ahead of print].

67.  Kapetanovic MC, Roseman C, Jönsson G, Truedsson L, Saxne T, Geborek P. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors. Arthritis Rheum. 2011 Dec; 63(12):3723-32.

68.  Kata A. Anti-vaccine activists, Web 2.0, and the postmodern paradigm - An overview of tactics and tropes used online by the anti-vaccination movement. Vaccine. 2011 Dec 13. [Epub ahead of print].

69.  Keijsers RR, Bovenschen HJ, Seyger MM. Cutaneous complication after BCG vaccination: case report and review of the literature. J Dermatolog Treat. 2011 Dec; 22(6):315-8.

70.  Khatami A, Peters A, Robinson H, Williams N, Thompson A, Findlow H, Pollard AJ, Snape MD. Maintenance of Immune Response throughout Childhood following Serogroup C Meningococcal Conjugate Vaccination in Early Childhood. Clin Vaccine Immunol. 2011 Dec; 18(12):2038-42.

71.  Khawplod P, Jaijaroensup W, Sawangvaree A, Prakongsri S, Wilde H. One clinic visit for pre-exposure rabies vaccination (a preliminary one year study). Vaccine. 2011 Dec 15. [Epub ahead of print].

72.  Khemiri M, Bagais A, Ben Becher S, Bousnina S, Bayoudh F, Mehrezi A, Lakhoua R, Barsaoui S. Tuberculous Meningitis in Bacille Calmette-Guerin-Vaccinated Children : Clinical Spectrum and Outcome. J Child Neurol. 2011 Dec 21. [Epub ahead of print].

73.  Khowaja AR, Zaman U, Feroze A, Rizvi A, Zaidi AK. Routine EPI Coverage: Subdistrict Inequalities and Reasons for Immunization Failure in a Rural Setting in Pakistan. Asia Pac J Public Health. 2011 Dec 20. [Epub ahead of print].

74.  Khurana S, Verma N, Talaat KR, Karron RA, Golding H. Immune Response Following H1N1pdm09 Vaccination: Differences in Antibody Repertoire and Avidity in Young Adults and Elderly Populations Stratified by Age and Gender. J Infect Dis. 2011 Dec 29. [Epub ahead of print].

75.  Kim CH, Kim JS, Cha SH, Kim KN, Kim JD, Lee KY, Kim HM, Kim JH, Hyuk S, Hong JY, Park SE, Kim YK, Kim NH, Fanic A, Borys D, Ruiz-Guiñazù J, Moreira M, Schuerman L, Kim KH. Response to primary and booster vaccination with 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in Korean infants. Pediatr Infect Dis J. 2011 Dec; 30(12):e235-43.

76.  Kiyohara K, Kojimahara N, Sato Y, Yamaguchi N. Changes in COPD mortality rate after amendments to the Preventive Vaccination Law in Japan. Eur J Public Health. 2011 Dec 12. [Epub ahead of print].

77.  Kontopantelis E, Doran T, Gravelle H, Goudie R, Siciliani L, Sutton M. Family Doctor Responses to Changes in Incentives for Influenza Immunization under the U.K. Quality and Outcomes Framework Pay-for-Performance Scheme. Health Serv Res. 2011 Dec 15. [Epub ahead of print].

78.  Kriwy P. Similarity of parents and physicians in the decision to vaccinate children against measles, mumps and rubella. Int J Public Health. 2011 Dec 16. [Epub ahead of print].

79.  Langley JM, Halperin SA, Rubin E, White C, Macneil S, Mutch J, Mackinnon-Cameron D, Smith B. Safety and Immunogenicity of Two Mixed Primary Infant Immunization Schedules of Pentavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliomyelitis, and Haemophilus influenzae Type b Vaccines at 2, 4, and 6 Months of Age: A Randomized Controlled Trial. Pediatr Infect Dis J. 2011 Dec 14. [Epub ahead of print].

80.  Lavelle TA, Meltzer MI, Gebremariam A, Lamarand K, Fiore AE, Prosser LA. Community-Based Values for 2009 Pandemic Influenza A H1N1 Illnesses and Vaccination-Related Adverse Events. PLoS One. 2011; 6(12):e27777.

81.  Lee S, Golinski M, Chowell G. Modeling Optimal Age-Specific Vaccination Strategies Against Pandemic Influenza. Bull Math Biol. 2011 Dec 7. [Epub ahead of print].

82.  Lessin HR, Edwards KM; the COMMITTEE ON PRACTICE AND AMBULATORY MEDICINE AND  THE COMMITTEE ON INFECTIOUS DISEASES. Immunizing Parents and Other Close Family Contacts in the Pediatric Office Setting. Pediatrics. 2012 Jan; 129(1):e247-e253.

83.  Levine H, Rishpon S, Huerta-Hartal M, Davidovitch N. Preventing mumps outbreaks in confined settings: Comprehensive ring vaccination as a containment strategy. Hum Vaccin. 2011 Dec 1; 7(12). [Epub ahead of print].

84.  Link-Gelles R, Chamberlain AT, Schulkin J, Ault K, Whitney E, Seib K, Omer SB. Missed Opportunities: A National Survey of Obstetricians About Attitudes on Maternal and Infant Immunization. Matern Child Health J. 2011 Dec 24. [Epub ahead of print].

85.  Loomba RS, Aggarwal S, Shah PH, Arora RR. Influenza Vaccination and Cardiovascular Morbidity and Mortality: Analysis of 292 383 Patients. J Cardiovasc Pharmacol Ther. 2011 Dec 14. [Epub ahead of print].

86.  Lu PJ, Callahan DB, Ding H, Euler GL. Influenza A (H1N1) 2009 monovalent vaccination among adults with asthma, U.S., 2010. Am J Prev Med. 2011 Dec; 41(6):619-26.

87.  Lutringer-Magnin D, Kalecinski J, Barone G, Borne H, Regnier V, Vanhems P, Chauvin F, Lasset C. [Gynaecologists' attitudes and practices towards HPV vaccination: A quantitative-qualitative study in Rhône-Alpes]. Gynecol Obstet Fertil. 2011 Dec; 39(12):687-93.

88.  Maire N, Shillcutt SD, Walker DG, Tediosi F, Smith TA. Cost-Effectiveness of the Introduction of a Pre-Erythrocytic Malaria Vaccine into the Expanded Program on Immunization in Sub-Saharan Africa: Analysis of Uncertainties Using a Stochastic Individual-Based Simulation Model of Plasmodium falciparum Malaria. Value Health. 2011 Dec; 14(8):1028-38

89.  Malmqvist E, Natunen K, Lehtinen M, Helgesson G. Just implementation of human papillomavirus vaccination. J Med Ethics. 2011 Dec 2. [Epub ahead of print].

90.  Marcuse EK. Reflections on US Immunization Challenges: Lady Montague, Where Are You? Pediatrics. 2011 Dec; 128(6):1192-4.

91.  Martinez JM. Managing Scientific Uncertainty in Medical Decision Making: The Case of the Advisory Committee on Immunization Practices. J Med Philos. 2011 Dec 23. [Epub ahead of print].

92.  Matysiak-Klose D, Ahmed F, Duclos P, Falck-Ytter Y, Forland F, Houweling H, Kramarz P, Langley JM, Mertens T, Schünemann H, Senouci K, Temte J, Wichmann O. Report on the 1st international workshop on procedures for the development of evidence-based vaccination recommendations, Berlin, Germany, 22-23 November 2010. Vaccine. 2011 Dec 13. [Epub ahead of print].

93.  Mayet A, Nivoix P, Haus-Cheymol R, De Laval F, Verret C, Duron S, Faure N, Piarroux M, Decam C, Chaudet H, Meynard JB, Deparis X, Migliani R. Increase in reported adverse events following seasonal influenza vaccination among the French armed forces, 2008-2009: Possible role of stimulated reporting and background cases of influenza-like infection. Public Health. 2012 Jan; 126(1):70-6.

94.  McMurray DN. Do new TB vaccines have a place in the Expanded Program on Immunization? Expert Rev Vaccines. 2011 Dec; 10(12):1675-7.

95.  Middleton DB, Zimmerman RK, Troy JA, Wolfe RM. Keeping up-to-date with immunization practices. Prim Care. 2011 Dec; 38(4):747-61, ix.

96.  Miller BL, Ahmed F, Lindley MC, Wortley PM. US hospital requirements for pertussis vaccination of healthcare personnel, 2011. Infect Control Hosp Epidemiol. 2011 Dec; 32(12):1209-12.

97.  Miller BL, Ahmed F, Lindley MC, Wortley PM. Institutional requirements for influenza vaccination of healthcare personnel: results from a nationally representative survey of acute care hospitals--United States, 2011. Clin Infect Dis. 2011 Dec; 53(11):1051-9.

98.  Moreno-Pérez D, Arístegui Fernández J, Ruiz-Contreras J, Alvarez García FJ, Merino Moína M, González-Hachero J, Corretger Rauet JM, Hernández-Sampelayo Matos T, Ortigosa Del Castillo L, Cilleruelo Ortega MJ, Barrio Corrales F. [Seasonal influenza vaccination in children and adolescents. Recommendations of the CAV-AEP for the campaign.]. An Pediatr (Barc). 2011 Dec 7. [Epub ahead of print].

99. Mortensen GL. Perceptions of herpes zoster and attitudes towards zoster vaccination among 50-65-year-old Danes. Dan Med Bull. 2011 Dec; 58(12):A4345.

100. Mueller JE, Yaro S, Njanpop-Lafourcade BM, Drabo A, Idohou RS, Kroman SS, Sanou O, Diagbouga S, Traoré Y, Sangaré L, Borrow R, Gessner BD. Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity. J Infect Dis. 2011 Dec; 204(11):1787-95.

101.  Murphy D, Marteau TM, Wessely S. A longitudinal study of UK military personnel offered anthrax vaccination: Informed choice, symptom reporting, uptake and pre-vaccination health. Vaccine. 2011 Dec 15. [Epub ahead of print].

102.  Ng AN, Lai CK. Effectiveness of seasonal influenza vaccination in healthcare workers: a systematic review. J Hosp Infect. 2011 Dec; 79(4):279-86.

103.  Olufowote JO. Local resistance to the global eradication of polio: newspaper coverage of the 2003-2004 vaccination stoppage in northern Nigeria. Health Commun. 2011 Dec; 26(8):743-53.

104.  Pitman RJ, White LJ, Sculpher M. Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales. Vaccine. 2011 Dec 13. [Epub ahead of print].

105.  Pitsiou GG, Kioumis IP. Pneumococcal vaccination in adults: does it really work? Respir Med. 2011 Dec; 105(12):1776-83.

106.  Pradhan N, Ryman TK, Varkey S, Ranjan A, Gupta SK, Krishna G, Swetanki RP, Young R. Expanding and improving urban outreach immunization in Patna, India. Trop Med Int Health. 2011 Dec 14. [Epub ahead of print].

107.  Raab CP. Passive immunization. Prim Care. 2011 Dec; 38(4):681-91, viii.

108.  Rabbone I, Scaramuzza AE, Iafusco D, Bonfanti R, Lombardo F, Cherubini V, Toni S, Cerutti F, Zuccotti GV. Pandemic influenza vaccination coverage in children with type 1 diabetes: Analysis from seven Italian centers. Hum Vaccin. 2011 Dec 1; 7(12). [Epub ahead of print].

109.  Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect. 2011 Dec; 87(7):544-7.

110.  Retrouvey M, Koch LH, Williams JV. Gianotti-Crosti Syndrome Following Childhood Vaccinations. Pediatr Dermatol. 2011 Dec 6. [Epub ahead of print].

111.  Ribeiro AC, Guedes LK, Moraes JC, Saad CG, Aikawa NE, Calich AL, França IL, Carvalho JF, Sampaio-Barros PD, Goncalves CR, Borba EF, Timenetsky Mdo C, Precioso AR, Duarte A, Bonfa E, Laurindo IM. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice. Ann Rheum Dis. 2011 Dec; 70(12):2144-7.

112.  Rightmier E, Stevens V, Brown J. Streptococcus pneumoniae Vaccination in Older Adults. Am J Geriatr Pharmacother. 2011 Dec; 9(6):392-404.

113.  Riphagen-Dalhuisen J, Gefenaite G, Hak E. Predictors of seasonal influenza vaccination among healthcare workers in hospitals: a descriptive meta-analysis. Occup Environ Med. 2011 Dec 15. [Epub ahead of print].

114.  Ritterhouse LL, Crowe SR, Niewold TB, Merrill JT, Roberts VC, Dedeke AB, Neas BR, Thompson LF, Guthridge JM, James JA. B lymphocyte stimulator levels in systemic lupus erythematosus: Higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels. Arthritis Rheum. 2011 Dec; 63(12):3931-41.

115.  Rodenburg GD, van Gils EJ, Veenhoven RH, Bogaert D, van den Dobbelsteen GP, Berbers GA, Sanders EA. Lower immunoglobulin G antibody responses to pneumococcal conjugate vaccination at the age of 2 years after previous nasopharyngeal carriage of Streptococcus pneumoniae. J Pediatr. 2011 Dec; 159(6):965-70.e1.

116.  Rodríguez-García J, Fernández-Santos R, García-Erce JA. [Vaccination of patients with Paroxysmal Nocturnal hemoglobinuria under eculizumab treatment.]. Med Clin (Barc). 2011 Dec 22. [Epub ahead of print].

117.  Romani MH, Musharrafieh UM, Lakkis NA, Hamadeh GN. Family physicians beliefs and attitudes regarding adult pneumococcal and influenza immunization in Lebanon. Fam Pract. 2011 Dec; 28(6):632-7.

118.  Ropero-Álvarez AM, Whittembury A, Kurtis HJ, Dos Santos T, Danovaro-Holliday MC, Ruiz-Matus C. Pandemic influenza vaccination: Lessons learned from Latin America and the Caribbean. Vaccine. 2011 Dec 11. [Epub ahead of print].

119.  Roukens AH, Soonawala D, Joosten SA, de Visser AW, Jiang X, Dirksen K, de Gruijter M, van Dissel JT, Bredenbeek PJ, Visser LG. Elderly Subjects Have a Delayed Antibody Response and Prolonged Viraemia following Yellow Fever Vaccination: A Prospective Controlled Cohort Study. PLoS One. 2011; 6(12):e27753.

120.  Ruiz LP Jr. Intussusception risk of rotavirus vaccination. N Engl J Med. 2011 Dec 1; 365(22):2137; author reply 2138.

121.  Rückinger S, Dagan R, Albers L, Schönberger K, von Kries R. Immunogenicity of pneumococcal conjugate vaccines in infants after two or three primary vaccinations: A systematic review and meta-analysis. Vaccine. 2011 Dec 6; 29(52):9600-6.

122.  Schaetti C, Chaignat CL, Hutubessy R, Khatib AM, Ali SM, Schindler C, Weiss MG. Social and cultural determinants of anticipated acceptance of an oral cholera vaccine prior to a mass vaccination campaign in Zanzibar. Hum Vaccin. 2011 Dec 1; 7(12). [Epub ahead of print].

123.  Schwartz JL, Caplan AL. Vaccination refusal: ethics, individual rights, and the common good. Prim Care. 2011 Dec; 38(4):717-28, ix.

124.  Selman MH, de Jong SE, Soonawala D, Kroon FP, Adegnika AA, Deelder AM, Hokke CH, Yazdanbakhsh M, Wuhrer M. Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination. Mol Cell Proteomics. 2011 Dec 19. [Epub ahead of print].

125.  Seror E, Blondé R, Naudin J, Armoogum P, Angoulvant F, De Lauzanne A, Lorrot M, Pull L, Mercier JC, Bourrillon A, Alberti C, Faye A. [Evaluation of pre-travel prevention, except vaccination, in children returning from Africa with fever]. Arch Pediatr. 2011 Dec; 18(12):1271-7.

126.  Sharma HJ, Padbidri VS, Kapre SV, Jadhav SS, Dhere RM, Parekh SS, Dudhane AD, Shewale SD, Namjoshi GS. Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India. J Infect Dev Ctries. 2011 Dec 13; 5(12):874-81.

127.  Shepherd SM, Shoff WH. Immunization in travel medicine. Prim Care. 2011 Dec; 38(4):643-79, viii.

128.  Skowronski DM, Janjua NZ, Sonfack Tsafack EP, Ouakki M, Hoang L, De Serres G. The Number Needed to Vaccinate to Prevent Infant Pertussis Hospitalization and Death Through Parent Cocoon Immunization. Clin Infect Dis. 2011 Dec 8. [Epub ahead of print].

129.  Sohn MW, Yoo J, Oh EH, Amsden LB, Holl JL. Welfare, maternal work, and on-time childhood vaccination rates. Pediatrics. 2011 Dec; 128(6):1109-16.

130.  Stokley S, Cohn A, Dorell C, Hariri S, Yankey D, Messonnier N, Wortley PM. Adolescent vaccination-coverage levels in the United States: 2006-2009. Pediatrics. 2011 Dec; 128(6):1078-86.

131.  Stromberg SP, Antia R. Vaccination by delayed treatment of infection. Vaccine. 2011 Dec 6; 29(52):9624-31.

132.  Sánchez-Payá J, Hernández-García I, García-Román V, Camargo-Angeles R, Barrenengoa-Sañudo J, Villanueva-Ruiz CO, Martínez HR, González-Hernández M. Influenza vaccination among healthcare personnel after pandemic influenza H1N1. Vaccine. 2011 Dec 7. [Epub ahead of print].

133.  Thorpe EL, Zimmerman RK, Steinhart JD, Lewis KN, Michaels MG. Homeschooling parents' practices and beliefs about childhood immunizations. Vaccine. 2011 Dec 14. [Epub ahead of print].

134.  Trayes KP, Conniff KM. Q & A: patient to physician FAQs: answers to common patient questions about vaccinations. Prim Care. 2011 Dec; 38(4):763-76, ix.

135.  Uhlig U, Kostev K, Schuster V, Uhlig HH. Rotavirus vaccination in Germany: analysis of nationwide surveillance data 2006 to 2010. Pediatr Infect Dis J. 2011 Dec; 30(12):e244-7.

136.  van den Hoek A, Sonder G, Scholing M, Gijselaar D, van Binnendijk R. Two cases of mild IgM-negative measles in previously vaccinated adults, the Netherlands, April and July 2011. Euro Surveill. 2011 Dec 1; 16(48).

137. Velan B. Acceptance on the move: Public reaction to shifting vaccination realities. Hum Vaccin. 2011 Dec 1; 7(12). [Epub ahead of print].

138.  Vic P, Puech J. [Health care workers' knowledge and vaccination coverage against pertussis in a French pediatric and maternity ward]. Arch Pediatr. 2011 Dec; 18(12):1334-5.

139.  Walmsley D. Routine pediatric immunization, special cases in pediatrics: prematurity, chronic disease, congenital heart disease: recent advancements/changes in pediatric vaccines. Prim Care. 2011 Dec; 38(4):595-609, vii.

140.  Wasan SK, Coukos JA, Farraye FA. Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge. Inflamm Bowel Dis. 2011 Dec; 17(12):2536-40.

141. Weber DJ, Consoli SA, Sickbert-Bennett E, Rutala WA. Assessment of a Mandatory Tetanus, Diphtheria, and Pertussis Vaccination Requirement on Vaccine Uptake over Time. Infect Control Hosp Epidemiol. 2012 Jan; 33(1):81-3.

142.  Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet. 2011 Dec 3; 378(9807):1962-73.

143.  Wightman A, Opel DJ, Marcuse EK, Taylor JA. Washington state pediatricians' attitudes toward alternative childhood immunization schedules. Pediatrics. 2011 Dec; 128(6):1094-9.

144.  Wilson K, Hawken S, Kwong JC, Deeks S, Crowcroft NS, Van Walraven C, Potter BK, Chakraborty P, Keelan J, Pluscauskas M, Manuel D. Adverse Events following 12 and 18 Month Vaccinations: a Population-Based, Self-Controlled Case Series Analysis. PLoS One. 2011; 6(12):e27897.

145.  Witteman HO, Zikmund-Fisher BJ. The defining characteristics of Web 2.0 and their potential influence in the online vaccination debate. Vaccine. 2011 Dec 15. [Epub ahead of print].

146.  Woerner A, Sauvain MJ, Aebi C, Otth M, Bolt IB. Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-α inhibitors. Hum Vaccin. 2011 Dec 1; 7(12). [Epub ahead of print].

147.  Wu Y, Wei W, Zhou M, Wang Y, Wu J, Ma G, Su Z. Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization. Biomaterials. 2011 Dec 20. [Epub ahead of print].

148.  Young JL, Bernheim RG, Korte JE, Stoler MH, Guterbock TM, Rice LW. Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists. J Pediatr Adolesc Gynecol. 2011 Dec; 24(6):380-5.